• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Breast screens for trans women stirs debate

Publication
Article
Diagnostic ImagingDiagnostic Imaging Vol 32 No 9
Volume 32
Issue 9

Breast screening habits for transsexual women shouldn't differ from those of biological women, according to a recent European study.

Breast screening habits for transsexual women shouldn't differ from those of biological women, according to a recent European study. However, a human sexuality expert disagrees, saying screening for transsexual women should depend on when the patient started estrogen therapy and not age alone.

The researchers found mammography and breast sonography were technically feasible in the 50 women who received sex-reassignment surgery. No gross anomalies were detected. In addition, 98% of the patients intended to come back for screening (EJR 2010;74:
508-513).

The study recommended a normal screening regimen for transsexual women. The mean age of study subjects was 43 ± 10.5 years.

Not everyone agrees with the study's conclusions, however.

Screening mammography for transsexual women should start at age 50, provided they have had five years of hormone therapy, said Dr. Jamie Feldman, an associate professor in the human sexuality program at the University of Minnesota.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.